IndustriesMedical

Products 21 to 29 of 29

INXN-3004: AML by Intrexon
Biotech components: Virus
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:59 (2 years ago)
Date last modified: 2020/02/10 09:59 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Mast-MO (antibiotic wasp venom) by University of Pennsylvania’s Perelman School of Medicine
Biotech components: Animal + Bacteria + Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (2 years ago)
Date last modified: 2020/12/18 14:40 (2 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Molecule
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (2 years ago)
Date last modified: 2020/12/18 14:39 (2 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medicine + Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
OG716: Lantibiotics by Oakbio + Oragenics
Biotech components: Molecule
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (3 years ago)
Date last modified: 2019/09/12 15:16 (3 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Medical
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
PRGN-3005: Cancer by Intrexon
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:31 (3 years ago)
Date last modified: 2019/09/12 14:31 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:32 (3 years ago)
Date last modified: 2019/09/12 14:32 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (2 years ago)
Date last modified: 2020/12/18 14:40 (2 years ago)
Known funding amount: 28,500,000 USD
Funding types: Private Funding
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Transgenic Strawberry Plants by Hokkai Sankyo Company Ltd
Biotech components: Gene Editing + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/01/21 15:00 (2 years ago)
Date last modified: 2020/01/21 15:00 (2 years ago)
Known funding amount: N/A
Funding types: Research Institution
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medicine
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Yeast
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:38 (2 years ago)
Date last modified: 2020/12/18 14:38 (2 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical + Multipurpose
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medicine + Other
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform